ArticleCNS neuroscience & therapeutics2026
SIX2-Mediated Microglial M2 Polarization and Exosomal miR-3470b Delivery Protect Dopaminergic Neurons in Parkinson's Disease.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SIX2-Mediated Microglial M2 Polarization and Exosomal miR-3470b Delivery Protect Dopaminergic Neurons in Parkinson's Disease.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsNeuroinflammation driven by dysregulated microglial activation exacerbates dopaminergic neuron loss in Parkinson's disease (PD). This study investigated whether the transcription factor SIX2 mitigates neuroinflammation and provides neuroprotection by promoting microglial M2 polarization and exosome-mediated communication.
methodsUsing LPS-stimulated BV2 microglia and MPTP-induced mouse models of PD, we systematically investigated the role of SIX2. Gain- and loss-of-function approaches for SIX2, DDIT4, miR-3470b, and GREM1 were combined with ChIP, RNA-seq, exosome isolation/transfer, and behavioral tests to analyze the SIX2-DDIT4-autophagy axis and the exosomal miR-3470b/GREM1/TGF-β pathway.
resultsRNA-seq and ChIP-qPCR revealed that SIX2 transcriptionally activated DDIT4. This led to mTOR inhibition and autophagy induction, driving a shift in microglial phenotype from pro-inflammatory M1 to protective M2. Consequently, M2-polarized microglia released exosomes highly enriched in miR-3470b, as identified by miRNA sequencing. Upon internalization by dopaminergic neurons, miR-3470b directly bound to and suppressed GREM1, which in turn potentiated TGF-β signaling activity. Ultimately, this SIX2-initiated cascade rescued neuronal apoptosis and restored motor coordination in both cellular and animal models of PD.
conclusionSIX2 promotes microglial M2 polarization via the DDIT4/mTOR/autophagy axis and mediates neuroprotection through exosomal miR-3470b targeting of GREM1/TGF-β signaling, revealing novel therapeutic targets for PD immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.